Citadel Advisors - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,246,659
+155.4%
1,769,023
+561.6%
0.00%
Q2 2023$879,667
+66.7%
267,376
+108.3%
0.00%
Q1 2023$527,564
-85.7%
128,361
-79.6%
0.00%
-100.0%
Q4 2022$3,689,316
+208.5%
629,576
+255.9%
0.00%
Q3 2022$1,196,000
-29.0%
176,903
-51.5%
0.00%
Q2 2022$1,685,000
-40.8%
364,515
-48.9%
0.00%
-100.0%
Q1 2022$2,847,000
+29.2%
713,489
+101.5%
0.00%
Q4 2021$2,203,000
+108.4%
354,107
+216.0%
0.00%
Q3 2021$1,057,000
-87.3%
112,043
-81.7%
0.00%
-100.0%
Q2 2021$8,301,000
-20.2%
611,223
-4.9%
0.00%0.0%
Q1 2021$10,396,000
-81.5%
642,507
-69.5%
0.00%
-86.7%
Q4 2020$56,132,000
+538.5%
2,109,417
+346.8%
0.02%
+650.0%
Q3 2020$8,791,000
-40.5%
472,095
-25.3%
0.00%
-60.0%
Q2 2020$14,780,000
+449.6%
631,601
+37.0%
0.01%
+400.0%
Q1 2020$2,689,000
+113.2%
461,186
+109.5%
0.00%0.0%
Q4 2019$1,261,000
+757.8%
220,102
+136.2%
0.00%
Q3 2019$147,000
-54.9%
93,174
+15.6%
0.00%
Q2 2019$326,000
+33.1%
80,621
+73.2%
0.00%
Q1 2019$245,000
+22.5%
46,538
-5.1%
0.00%
Q4 2018$200,000
+11.7%
49,042
+282.4%
0.00%
Q2 2017$179,00012,8240.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders